SCHEMBL12827128

SCHEMBL12827128

CCc1ccc2[nH]c(C(C)(C)C)c(N)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.42
▸ HTR1A P08908 2/20 0.41
▸ HTR1D P28221 2/20 0.41
▸ HTR1B P28222 2/20 0.41
▸ KDM4E B2RXH2 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MAPK10 P53779 1/20 0.37
▸ RIPK1 Q13546 1/20 0.37
▸ TYMS P04818 1/20 0.37
▸ HPGD P15428 2/20 0.35
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA7 P36544 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ KMT2A Q03164 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10067388 0.82 NPC1 (0.44) KIF11HTR1AHTR1DHTR1BKDM4E
SCHEMBL29954927 0.80 KIF11 (0.40) KIF11HTR1AHTR1DHTR1BKDM4E
SCHEMBL13362014 0.78 KIF11 (0.41) KIF11HTR1DKDM4EALDH1A1NPC1
SCHEMBL15099974 0.78 ALDH1A1 (0.47) KIF11KDM4EALDH1A1NPC1RAB9A
SCHEMBL12846524 0.78 KIF11 (0.54) KIF11HTR1AHTR1DHTR1BALDH1A1
SCHEMBL30458204 0.74 KIF11 (0.62) KIF11HTR1AHTR1DHTR1BKDM4E
SCHEMBL5494899 0.74 KIF11 (0.62) KIF11HTR1AHTR1DHTR1BKDM4E
SCHEMBL13768726 0.72 KIF11 (0.44) KIF11HTR1AHTR1DHTR1BKDM4E
SCHEMBL31377086 0.72 HPGD (0.56) KIF11KDM4EALDH1A1SMN1; SMN2GAA
SCHEMBL2056416 0.69 KDM4E (0.45) KIF11HTR1AHTR1DHTR1BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110071206-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-03-24 — — US disclosed
US-7645789-B2 Indole derivatives as CFTR modulators VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-01-12 — — US disclosed
US-20090131492-A1 Indole derivatives as CFTR modulators VERTEX PHARMACEUTICALS INCORPORATED 2009-05-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071206-A1 Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 KIF11 4624/4885HTR1A 3291/4885HTR1D 3898/4885
US-20090131492-A1 Indole derivatives as CFTR modulators CFTR, ABCB1, ABCB11 KIF11 3667/4885HTR1A 317/4885HTR1D 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback